Sort   by:  
 Page size 
UnknownVorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.
Not available
S-EPMC2795066 | biostudies-literature
UnknownRandomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.
Not available
S-EPMC5320944 | biostudies-literature
UnknownRandomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC5321098 | biostudies-literature
UnknownPersonalized therapy for lung cancer: striking a moving target.
Not available
S-EPMC6129126 | biostudies-literature
UnknownRandomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer.
Not available
S-EPMC5478045 | biostudies-literature
UnknownPhase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Not available
S-EPMC12648153 | biostudies-literature
UnknownA Dual-Plasmid-Based CRISPR/Cas9-Mediated Strategy Enables Targeted Editing of pH Regulatory Gene pacC in a Clinical Isolate of Trichophyton rubrum.
Not available
S-EPMC9782554 | biostudies-literature
UnknownSmall Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
Not available
S-EPMC6456974 | biostudies-literature
UnknownGenotype Phenotype Correlation of Genetic Polymorphism of PPAR Gamma Gene and Therapeutic Response to Pioglitazone in Type 2 Diabetes Mellitus- A Pilot Study.
Not available
S-EPMC4800546 | biostudies-literature
UnknownTargeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations.
Not available
S-EPMC7723684 | biostudies-literature
Sort   by:  
 Page size